Identification of a new inhibitor of KRAS-PDEδ interaction targeting KRAS mutant nonsmall cell lung cancer

International Journal of Cancer. Journal International Du Cancer
Elaine Lai-Han LeungLiang Liu

Abstract

Oncogenic KRAS is considered a promising target for anti-cancer therapy. However, direct pharmacological strategies targeting KRAS-driven cancers remained unavailable. The prenyl-binding protein PDEδ, a transporter of KRAS, has been identified as a potential target for pharmacological inhibitor by selectively binding to its prenyl-binding pocket, impairing oncogenic KRAS signaling pathway. Here, we discovered a novel PDEδ inhibitor (E)-N'-((3-(tert-butyl)-2-hydroxy-6,7,8,9-tetrahydrodibenzo[b,dfuran-1-yl)methylene)-2,4-dihydroxybenzohydrazide(NHTD) by using a high-throughput docking-based virtual screening approach. In vitro and in vivo studies demonstrated that NHTD suppressed proliferation, induced apoptosis and inhibited oncogenic K-RAS signaling pathways by disrupting KRAS-PDEδ interaction in nonsmall cell lung cancer (NSCLC) harboring KRAS mutations. NHTD redistributed the localization of KRAS to endomembranes by targeting the prenyl-binding pocket of PDEδ and exhibited the suppression of abnormal KRAS function. Importantly, NHTD prevented tumor growth in xenograft and KRAS mutant mouse model, which presents an effective strategy targeting KRAS-driven cancer.

References

Oct 17, 2003·The Journal of Biological Chemistry·Houbin ZhangWolfgang Baehr
Mar 19, 2004·Journal of Medicinal Chemistry·Thomas A HalgrenJay L Banks
Jul 15, 2005·The New England Journal of Medicine·Ming-Sound TsaoFrances A Shepherd
May 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·H ZhangW Baehr
Jun 2, 2007·Cell·Johannes L BosAlfred Wittinghofer
Oct 24, 2008·Nature Reviews. Molecular Cell Biology·Sandra Iden, John G Collard
Oct 29, 2010·Respiratory Research·Sevdalina NikolovaSoni S Pullamsetti
Nov 26, 2010·Nature Reviews. Cancer·Dominico VigilChanning J Der
Oct 14, 2011·Nature Reviews. Cancer·Yuliya Pylayeva-GuptaDafna Bar-Sagi
Oct 18, 2011·Nature Chemical Biology·Shehab A IsmailAlfred Wittinghofer
Jan 28, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Liang ChengShaobo Zhang
Feb 3, 2012·Nature Cell Biology·Mark R Philips
Feb 14, 2012·Nature Medicine·Kengo TakeuchiYuichi Ishikawa
Nov 6, 2012·Clinical Lung Cancer·Niki KarachaliouRafael Rosell
Nov 13, 2012·Current Opinion in Chemical Biology·Elaina A ZverinaCarol A Fierke
Mar 22, 2014·Cancer Cell·Andrew G StephenFrank McCormick
Jun 16, 2014·Nature Chemical Biology·Jochen SpiegelHerbert Waldmann
Jul 25, 2014·Nature Reviews. Cancer·Zhao ChenKwok-Kin Wong
Sep 5, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Mauricio BurottoArun Rajan
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Oct 18, 2014·Nature Reviews. Drug Discovery·Adrienne D CoxChanning J Der
Dec 4, 2014·The New England Journal of Medicine·Benjamin J SolomonUNKNOWN PROFILE 1014 Investigators
Apr 17, 2015·Nature·Heidi Ledford
May 16, 2015·Cancer Metastasis Reviews·Stefan Zimmermann, Solange Peters
Dec 15, 2015·Cancer Research·Ruth NussinovHyunbum Jang
Jan 28, 2016·Chemical Reviews·Shaoyong LuJian Zhang
Mar 18, 2016·Journal of Cell Science·G Aaron HobbsKent L Rossman
Apr 21, 2016·Nature Communications·Björn PapkePhilippe I H Bastiaens
Apr 23, 2016·Cell·Sai Krishna Athuluri-DivakarE Premkumar Reddy
Nov 3, 2016·Proceedings of the National Academy of Sciences of the United States of America·Srisathiyanarayanan DharmaiahDhirendra K Simanshu
Jan 6, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Feb 25, 2017·Cell·Matthew E WelschBrent R Stockwell

❮ Previous
Next ❯

Citations

Sep 3, 2019·Current Topics in Medicinal Chemistry·Na YeJia Zhou
Jun 13, 2020·Nature Reviews. Drug Discovery·Amanda R MooreShiva Malek
Sep 6, 2019·Current Topics in Medicinal Chemistry·Hai-Zhou WuYan Cheng
May 9, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Ze-Bo JiangElaine Lai-Han Leung
Jul 15, 2021·Pathology Oncology Research : POR·Ai YangMingzhi Fang
Jul 25, 2021·Journal of Hematology & Oncology·Kun ChenPeng Wang
Aug 8, 2021·Cancers·Anxo Rio-VilariñoArancha Cebrián

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.